Europe Small Molecule Targeted Cancer Therapy Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Small Molecule Targeted Cancer Therapy Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Monoclonal Antibodies Market Performance (Volume)
  • 2.1.2 Small Molecules Market Performance (Volume)
  • 2.1.3 Small Molecule Drug Conjugates Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Monoclonal Antibodies Market Performance (Value)
  • 2.1.2 Small Molecules Market Performance (Value)
  • 2.1.3 Small Molecule Drug Conjugates Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Application 1 Market Performance (Volume)
  • 3.1.2 Application 2 Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 OncoGenex Pharmaceuticals
  • 4.1.1 OncoGenex Pharmaceuticals Profiles
  • 4.1.2 OncoGenex Pharmaceuticals Product Information
  • 4.1.3 OncoGenex Pharmaceuticals Small Molecule Targeted Cancer Therapy Business Performance
  • 4.1.4 OncoGenex Pharmaceuticals Small Molecule Targeted Cancer Therapy Business Development and Market Status
• 4.2 Cytokinetics
  • 4.2.1 Cytokinetics Profiles
  • 4.2.2 Cytokinetics Product Information
  • 4.2.3 Cytokinetics Small Molecule Targeted Cancer Therapy Business Performance
  • 4.2.4 Cytokinetics Small Molecule Targeted Cancer Therapy Business Development and Market Status
• 4.3 Hospira
  • 4.3.1 Hospira Profiles
  • 4.3.2 Hospira Product Information
  • 4.3.3 Hospira Small Molecule Targeted Cancer Therapy Business Performance
  • 4.3.4 Hospira Small Molecule Targeted Cancer Therapy Business Development and Market Status
• 4.4 GlaxoSmithKline
  • 4.4.1 GlaxoSmithKline Profiles
  • 4.4.2 GlaxoSmithKline Product Information
  • 4.4.3 GlaxoSmithKline Small Molecule Targeted Cancer Therapy Business Performance
  • 4.4.4 GlaxoSmithKline Small Molecule Targeted Cancer Therapy Business Development and Market Status
• 4.5 Boehringer Ingelheim
  • 4.5.1 Boehringer Ingelheim Profiles
  • 4.5.2 Boehringer Ingelheim Product Information
  • 4.5.3 Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Business Performance
  • 4.5.4 Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Business Development and Market Status
• 4.6 Bayer HealthCare
  • 4.6.1 Bayer HealthCare Profiles
  • 4.6.2 Bayer HealthCare Product Information
  • 4.6.3 Bayer HealthCare Small Molecule Targeted Cancer Therapy Business Performance
  • 4.6.4 Bayer HealthCare Small Molecule Targeted Cancer Therapy Business Development and Market Status
• 4.7 Abbott Laboratories
  • 4.7.1 Abbott Laboratories Profiles
  • 4.7.2 Abbott Laboratories Product Information
  • 4.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Business Performance
  • 4.7.4 Abbott Laboratories Small Molecule Targeted Cancer Therapy Business Development and Market Status

5 Market Performance for Manufacturers

• 5.1 Europe Small Molecule Targeted Cancer Therapy Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Europe Small Molecule Targeted Cancer Therapy Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Europe Small Molecule Targeted Cancer Therapy Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Europe Small Molecule Targeted Cancer Therapy Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Germany Market Performance for Manufacturers
  • 6.1.1 Germany Small Molecule Targeted Cancer Therapy Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Germany Small Molecule Targeted Cancer Therapy Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Germany Small Molecule Targeted Cancer Therapy Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Germany Small Molecule Targeted Cancer Therapy Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 UK Market Performance for Manufacturers
  • 6.2.1 UK Small Molecule Targeted Cancer Therapy Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 UK Small Molecule Targeted Cancer Therapy Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 UK Small Molecule Targeted Cancer Therapy Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 UK Small Molecule Targeted Cancer Therapy Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 France Market Performance for Manufacturers
  • 6.3.1 France Small Molecule Targeted Cancer Therapy Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 France Small Molecule Targeted Cancer Therapy Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 France Small Molecule Targeted Cancer Therapy Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 France Small Molecule Targeted Cancer Therapy Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Russia Market Performance for Manufacturers
  • 6.4.1 Russia Small Molecule Targeted Cancer Therapy Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Russia Small Molecule Targeted Cancer Therapy Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Russia Small Molecule Targeted Cancer Therapy Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Russia Small Molecule Targeted Cancer Therapy Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Benelux Market Performance for Manufacturers
  • 6.5.1 Benelux Small Molecule Targeted Cancer Therapy Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Benelux Small Molecule Targeted Cancer Therapy Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Benelux Small Molecule Targeted Cancer Therapy Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Benelux Small Molecule Targeted Cancer Therapy Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Italy Market Performance for Manufacturers
  • 6.6.1 Italy Small Molecule Targeted Cancer Therapy Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Italy Small Molecule Targeted Cancer Therapy Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Italy Small Molecule Targeted Cancer Therapy Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Italy Small Molecule Targeted Cancer Therapy Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Spain Market Performance for Manufacturers
  • 6.7.1 Spain Small Molecule Targeted Cancer Therapy Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Spain Small Molecule Targeted Cancer Therapy Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Spain Small Molecule Targeted Cancer Therapy Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Spain Small Molecule Targeted Cancer Therapy Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Small Molecule Targeted Cancer Therapy Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Small Molecule Targeted Cancer Therapy Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Small Molecule Targeted Cancer Therapy Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Small Molecule Targeted Cancer Therapy Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Europe Small Molecule Targeted Cancer Therapy Market Performance (Sales Point)

• 7.1 Europe Small Molecule Targeted Cancer Therapy Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Europe Small Molecule Targeted Cancer Therapy Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Europe Small Molecule Targeted Cancer Therapy Price (USD/Unit) by Regions 2013-2018
• 7.4 Europe Small Molecule Targeted Cancer Therapy Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Europe Small Molecule Targeted Cancer Therapy Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Germany Small Molecule Targeted Cancer Therapy Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 UK Small Molecule Targeted Cancer Therapy Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 France Small Molecule Targeted Cancer Therapy Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Russia Small Molecule Targeted Cancer Therapy Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Benelux Small Molecule Targeted Cancer Therapy Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Italy Small Molecule Targeted Cancer Therapy Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Small Molecule Targeted Cancer Therapy Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Small Molecule Targeted Cancer Therapy Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Application 1 Industry
• 11.2 Application 2 Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Europe Small Molecule Targeted Cancer Therapy Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Europe Small Molecule Targeted Cancer Therapy Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Germany Small Molecule Targeted Cancer Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 UK Small Molecule Targeted Cancer Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 France Small Molecule Targeted Cancer Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Russia Small Molecule Targeted Cancer Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Benelux Small Molecule Targeted Cancer Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Italy Small Molecule Targeted Cancer Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Spain Small Molecule Targeted Cancer Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Monoclonal Antibodies Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Small Molecules Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.4 Small Molecule Drug Conjugates Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Application 1 Sales and and Growth Rate 2019-2024
  • 12.4.3 Application 2 Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Europe Small Molecule Targeted Cancer Therapy Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Europe Small Molecule Targeted Cancer Therapy Gross Profit Trend 2019-2024

13 Conclusion